Sun Pharma banks on specialty drug portfolio, India business to drive growth in FY27

Sun Pharma targets FY27 growth via specialty drugs and India business.

Key growth drivers include established brands Ilumya, Cequa, and Odomzo.

Recently launched products Leqselvi and Unloxcyt are expected to contribute to growth.

The company communicated these plans during its Q1 earnings call with analysts.